Browse Guidelines

Acute Leukemia Guideline
Breast Cancer Guideline

Guideline News

Guideline Education

Melanoma CPG Webinars

  • Case Studies – on-demand recording available here
  • Practical Management Pearls – on-demand recording available here

Gastrointestinal Cancer CPG Webinars

  • Case Studies – on-demand recording available here
  • Practical Management Pearls – on-demand recording available here

About SITC CPG Education

SITC is pleased to offer free live and on-demand companion educational resources in support of published CPGs. These activities are designed to provide a deeper understanding of the recommendations in the SITC guidelines and how to apply them in various clinical scenarios.

Click here to view all available CPG educational resources. 

Acute Leukemia Guideline
Breast Cancer Guideline

Gastrointestinal Cancer Guideline

Gynecologic Cancer Guideline

Head and Neck Squamous Cell Carcinoma Guideline
Hepatocellular Carcinoma Guideline
ICI-related Adverse Events Guideline
IEC-related Adverse Events Guideline

Lung Cancer and Mesothelioma Guideline

Lymphoma Guideline

Melanoma Guideline

Multiple Myeloma Guideline

Nonmelanoma Skin Cancer Guideline

Prostate Carcinoma Guideline
Renal Cell Carcinoma Guideline
Urothelial Cancer Guideline

Cancer Immunotherapy Guidelines Program

Cancer Immunotherapy Guidelines Oversight Committee

The Cancer Immunotherapy Guidelines Oversight Committee oversees the development of new clinical practice guidelines and updates for existing guidelines that provide guidance on the appropriate treatment algorithms and recommended administration of FDA-approved cancer immunotherapies as well as mitigating and managing adverse events.

The committee determines the policies and protocols for the general guideline development process as well as the standards the expert panels must meet to ensure the recommendations are unbiased, relevant, and facilitate clinical decision-making leading to optimal patient care.

The committee also provides strategic insights into the existing dissemination efforts such as guideline education and mobile app development as well as envisions and informs new dissemination tactics.

About the Guidelines

The SITC Cancer Immunotherapy Guidelines program is a collection of Clinical Practice Guidelines (CPGs) developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve outcomes for patients with cancer.

These CPGs offer a vital resource for the practicing oncology community. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure a fair, transparent and balanced process for creating the CPGs. Each CPG expert panel is comprised of a comprehensive mix of academic physicians and researchers, nurses, patients, and patient advocates invited from institutions across the United States.

The guidelines are reviewed on an ongoing basis to account for newly available clinical trial data and FDA approvals.

For questions regarding the SITC CPGs, please contact a member of the Scientific Publications Department at scientificresources@sitcancer.org.